Because tumor aggressiveness is associated with higher tumor metabolic activity and the expression of glutamine metabolism-related proteins, these findings imply that evaluation of GLS1 positivity could provide useful information regarding patient prognosis. The gene discussed is GLS; the disease is neoplasm.